GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medical Cannabis Payment Solutions REFG · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 5 Nov 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2022

Revenue

—

FY2014FY2022

Net income

−$34,101

FY2014FY2022

Free cash flow

−$1,883

FY2014FY2022

Shareholders' equity

−$2.3m

FY2014FY2022

Income statement

Fiscal years

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue————————$5,000
Gross profit−$21,917−$21,917−$12,658−$2,836———−$1,040$3,960
Research and development—$120,000—$332,600————$25,521
Operating income−$34,100−$1.8m−$509,030−$565,836−$340,710−$4.2m−$509,650−$393,450−$260,776
Net income−$34,101−$1.6m−$333,793−$826,863−$1.3m−$4.3m−$509,652−$398,947−$271,110
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.01-0.00-0.00-0.00

Balance sheet

At each fiscal year end

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets$38,238$62,038$82,082$104,530$25,018$53$70$169,745$288,049
Cash and short-term investments—$1,883$10$14$18$28$70$167,058$284,322
Total liabilities$2.4m$2.4m$917,596$922,749$276,249$307$174$161,703$147,724
Debt$857,764$857,764$782,764$804,000$137,500$230$141$137,500$137,500
Shareholders' equity−$2.3m−$2.3m−$835,514−$818,219−$251,230−$254−$104$8,042$140,325
Shares outstanding608m608m544m473m460m445m220m608m608m

Cash flow

Fiscal years

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations−$1,883−$323,126−$242,636−$889,363−$1.3m−$4.2m−$497,470−$383,929−$263,237
Capital spending—−$4−$55,550−$17,016—−$3——−$3
Free cash flow−$1,883−$323,130−$298,186−$906,379−$1.3m−$4.2m−$497,470−$383,929−$263,240

Latest quarters

By quarter end

Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021
Gross profit−$5,479−$5,480−$5,479−$5,479−$5,479−$5,479−$5,479−$5,479
Operating income−$5,479−$5,780−$8,680−$7,779−$11,860−$30,000−$1.2m−$164,695
Net income−$5,479−$5,780−$8,680−$7,779−$11,862−$30,000−$1.2m−$165,000
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assets$32,759$38,238$43,718$49,197$54,676$62,038$67,517$72,996
Cash and short-term investments—————$1,883$1,883$1,883
Debt$857,764$857,764$857,764$857,764$857,764$857,764$857,764$857,764
Shareholders' equity−$2.3m−$2.3m−$2.3m−$2.3m−$2.3m−$2.3m−$2.3m−$1.0m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-60.8%-61.9%-10.9%
Net income-65.5%-61.9%-11.4%

Valuation history

At each fiscal year end

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013
Price to earnings-0.6-0.0-0.5-0.0-0.0-0.1-0.3-0.3-0.5-2.5
Price to sales————————27.6—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%40%82%-40%-82%935%-70%-70%-48%185%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1000-to-1 reverse split · 15 Feb 2012
  • 50-to-1 reverse split · 23 Dec 2005

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.